Professional-grade CBD topicals recommended by 850+ licensed practitioners nationwide — engineered for adults who need real, lasting relief.
Three SKUs. Every patient need covered. Designed for clinical recommendation.
Flagship clinical topical with advanced emulsion delivery system.
Cooling formula with menthol for immediate sensory relief. TRPM8 receptor activation for fast-acting comfort.
Mess-free roll-on for targeted application. Ideal take-home product for patients between visits.
Why Practitioners Choose Kannaco
Every product in this collection is formulated to meet the standards practitioners demand — not the minimums the market accepts.
Our nano-emulsion delivery system achieves up to 35% bioavailability — up to 6× higher than standard oil-based CBD topicals that never reach target tissue.
15 of 16 randomized controlled trials confirm measurable outcomes for pain relief and inflammation reduction — not anecdotal claims, real data.
Every batch is independently tested. COAs are available on every product page — potency, purity, and contaminant panels included.
Kannaco holds LegitScript certification — the highest compliance standard in the CBD industry, required by Google, Facebook, and major payment processors.
Licensed practitioners receive exclusive wholesale pricing, flexible MOQs, and dedicated account support — not a generic affiliate link.
Our clinical team provides dosing guidance, patient education materials, and ongoing support so you can recommend with confidence.
Kannaco uses a proprietary nano-emulsion delivery system that reduces cannabinoid particle size to under 100 nanometers. This allows active compounds to penetrate the stratum corneum and reach target tissue — something standard oil-based topicals cannot achieve. Our bioavailability data (up to 35%) is validated in peer-reviewed pharmacokinetic studies, not internal testing.
Yes. 15 of 16 randomized controlled trials examining topical cannabinoids for musculoskeletal discomfort have demonstrated statistically significant outcomes.
These studies are published in peer-reviewed journals including the Journal of Pain Research and European Journal of Pain. We provide a full clinical reference library to all wholesale practitioners upon account approval.
Click the 'Apply for Wholesale' button on any collection or product page. You'll complete a short verification form (license type, license number, practice name). Our team reviews applications within 24 hours on business days. Once approved, your account is automatically upgraded to wholesale pricing across all products.
Kannaco wholesale accounts are available to licensed practitioners including: Medical Doctors (MD/DO), Chiropractors (DC), Physical Therapists (PT/DPT), Naturopathic Doctors (ND), Registered Nurses and Nurse Practitioners (RN/NP/APRN), Licensed Massage Therapists (LMT), Acupuncturists (LAc), and Sports Medicine Physicians. If your license type is not listed, contact our team — we review all applications individually.
No minimum order quantity is required on your first wholesale purchase — we want you to sample the full range before committing to larger orders. After your first order, a soft MOQ of $150 per order applies to maintain wholesale pricing. There are no subscription commitments or auto-ship requirements.
Every product page includes a direct link to the current batch COA from our ISO-accredited third-party lab. COAs include full cannabinoid potency panels, residual solvent testing, heavy metals, pesticides, and microbial contaminants. If you need COAs for a specific lot number or historical batch, contact your account manager and we'll provide them within one business day.
LegitScript is the highest compliance standard in the CBD and supplement industry. It is required by Google, Meta, and major payment processors to run advertising for CBD products. For practitioners, it means Kannaco has passed rigorous verification of product claims, labeling accuracy, ingredient sourcing, and business practices. Recommending a LegitScript-certified brand protects your practice from liability associated with unverified supplement recommendations.
Yes. Wholesale practitioners receive access to our patient education library, including product comparison sheets, dosing guides, and condition-specific recommendation protocols. These materials are designed to support practitioner-patient conversations and are formatted for in-office distribution. All materials are reviewed by our clinical advisory board and updated quarterly.
Our flagship topicals combine CBD (cannabidiol) with CBG (cannabigerol) in a clinically-informed ratio. CBG acts on CB1 and CB2 receptors with a distinct mechanism from CBD — together they produce what researchers call the 'entourage effect,' where cannabinoids work synergistically for greater efficacy than either compound alone. CBG has demonstrated particular affinity for α2-adrenoceptors, which play a role in pain modulation.
Wholesale orders over $250 ship free via ground (2–5 business days). Expedited shipping (1–2 business days) is available at cost. All orders ship from our fulfillment center in Colorado within 1 business day of order placement. Tracking is provided via email and accessible in your account dashboard. We do not currently ship internationally for wholesale accounts.
No questions in this category yet.
Research & Evidence
ECS research spans more than three decades and thousands of peer-reviewed studies. Here are the key milestones that shaped our understanding of this remarkable system — and why it matters for your wellness today.
Dr. Allyn Howlett and William Devane identified the first cannabinoid receptor (CB1) in the rat brain, establishing the biological basis for how cannabinoids affect the nervous system.
Source: Howlett et al., Molecular Pharmacology, 1988Researchers at Hebrew University discovered anandamide, the first endocannabinoid — a naturally occurring compound produced by the human body that binds to the same receptors as THC.
Source: Devane et al., Science, 1992The second major cannabinoid receptor, CB2, was discovered in the immune system. This finding revealed that the ECS plays a significant role in immune regulation and peripheral tissue response.
Source: Munro et al., Nature, 19932-arachidonoylglycerol (2-AG) was identified as the most abundant endocannabinoid in the body, with full agonist activity at both CB1 and CB2 receptors — playing a key role in immune and neurological regulation.
Source: Mechoulam et al., Biochemical Pharmacology, 1995The Israeli chemist who first isolated THC in 1964 formally characterized the endocannabinoid system as a unified regulatory network, coining the term and establishing its role in maintaining homeostasis.
Source: Mechoulam & Ben-Shabat, European Journal of Biochemistry, 1999The U.S. Department of Health and Human Services was granted Patent #6,630,507 for cannabinoids as antioxidants and neuroprotectants, acknowledging their therapeutic potential.
Source: U.S. Patent 6,630,507, 2003Researchers confirmed the presence of both CB1 and CB2 receptors throughout human skin — in keratinocytes, hair follicles, sebaceous glands, and sensory nerve fibers — validating the mechanism for topical cannabinoid activity.
Source: Bíró et al., Trends in Pharmacological Sciences, 2009Dr. Ethan Russo proposed and documented Clinical Endocannabinoid Deficiency (CECD) as a condition where insufficient ECS tone may contribute to chronic discomfort, sleep disruption, and mood challenges.
Source: Russo, Cannabis and Cannabinoid Research, 2016We are the preferred topical for over 250 healthcare professionals — chiropractors, physical therapists, and physicians — who recommend it to their patients and use it themselves.
I use Kannaco products personally and recommend them to my patients. The formulation quality, third-party testing, and reliable results make it a staple in my practice. I've never found a topical that converts as consistently from treatment to retail.
As a chiropractor, I'm extremely selective about what I recommend to patients. Kannaco meets every standard I require: clean ingredients, verified potency, and results my patients can actually feel. The Pro Cream has become my go-to recommendation for soft tissue support.
The clinical glide on the Pro Cream is exceptional for IASTM and manual therapy. It absorbs quickly, leaves no residue on instruments, and my patients consistently report improved comfort after treatment. I recommend it for home use as well.
My patients over 60 are always looking for non-systemic options that actually work. Kannaco's topicals give them a clinically credible choice I can stand behind. The full-spectrum formulation and zero-THC options make it easy to recommend across my entire patient panel.
